Skip to content
Institute for Cancer Research
CLOSE
Institute for Cancer Research
Search
Home
»
Press and Media
»
First-in-class targeted microRNA therapy slows cancer tumor growth
September 5, 2023
First-in-class targeted microRNA therapy slows cancer tumor growth